Prospective Study on the Efficacy and Safety of 2 Week or 3 Week Xelox Regimen for Adjuvant Chemotherapy in CRC
NCT03564912
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
160
Enrollment
OTHER
Sponsor class
Conditions
Colorectal Cancer
Interventions
DRUG:
Capecitabine Oral Tablet [Xeloda]
Sponsor
Zhejiang University